Frontlight ResearchEarly access
Taking peopleNo phase
Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C
Key facts
- Who runs it
- NGMedical GmbH
- Where
- Austria and Germany7 sites in 2 countriesChoose a country to see its sites
- Trial code
- NCT05035693
- DRKS00022971
- Status
- Recruiting
- People taking part
- 170 people, planned
- Started
- 11 Mar 2021
- Expected to end
- 11 Mar 2027
- Type of study
- Interventional
- Treatments tested
- MOVE®-C
- Record updated
- 15 November 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Diagnosis of discopathy or disc hernia with radiculopathy or stenosis of the foramen and spinal canal,
- documented individual history of neck and/or upper extremity pain and/or functional/neurological deficit associated with the cervical level to be treated,
- no surgical treatment regarding the planned index surgery within the last six weeks prior implantation,
- unsuccessful conservative medical care regarding the indication within the last six weeks,
- age ≥18 years,
- patient must agree to fully participate in the clinical trial and give informed consent in writing,
- patient is capable to realise the nature, aims and possible consequences of the clinical trial (MPG §20.2.1),
- patient information has been provided and all written consents of the patient are available
Who cannot take part
- Known contraindication against the use of cervical intervertebral disc prostheses in accordance with the manufacturer's instructions for use:; Bone mineral density with T-score ≤ -1.5 as determined by spine DXA if male ≥ 60 years of age or female ≥ 50 years of age,; active systemic infection or infection at the operative site,; sustained osteoporotic fracture of the spine, hip or wrist,; spinal metastases,; known allergy to titanium or polycarbonate-urethane,; confirmed pregnancy,; severe cervical myelopathy,; patients requiring a treatment that destabilises the spine (e.g. posterior element decompression),; advanced cervical anatomical deformity at the operative site (e.g. ankylosing spondylitis, scoliosis),; advanced degenerative changes (e.g. spondylosis) at the index vertebral level,; patient is kept in an institution under judicial or official orders (MPG §20.3)
This trial is currently available in Austria and Germany.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Study design: International, prospective, multicentre, non-randomised, observational study according to § 23b MPG.
Read full original descriptionShow less
Objectives: Observational study to confirm the safety and performance of the cervical disc prosthesis MOVE®-C.
The group in the trial
- PMCF MOVE-CTreatment being tested
PMCF MOVE®\_C is a single arm observational study with 170 patients.
Treatment: MOVE®-C
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- "PMCF MOVE®-C" International, Prospective, Multicentre, Non-randomised Post-market Clinical Follow-up Study Clinical and Radiological Outcome After Mono- and Bisegmental Cervical Intervertebral Disc Prosthetics
- Record updated
- 15 November 2024